Predictors of Clinical Response to Fractional CO2 Laser Therapy in Women with Mild-to-Moderate Stress Urinary Incontinence: A Two-Center Pilot Study
DOI:
https://doi.org/10.20883/medical.e1596Keywords:
stress urinary incontinence, CO₂ laser, urethral mobility, predictors, urogynecologyAbstract
Background. Stress urinary incontinence (SUI) is a common urogynecological condition with a substantial impact on quality of life. Fractional CO₂ laser therapy has emerged as a minimally invasive treatment for mild-to-moderate SUI; however, data on predictors of treatment response remain limited. This study aimed to assess clinical, questionnaire-based, and ultrasound parameters associated with outcomes following CO₂ laser therapy.
Material and methods. This prospective two-centre study included 31 women aged 33–66 years with grade 1–2 SUI. Participants completed validated questionnaires, including the Urogenital Distress Inventory (UDI-6), the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), and visual analogue scales (VAS) for urogynecological symptoms. Pelvic floor ultrasound evaluated urethral length, resting position, and mobility during voluntary contraction and Valsalva. All patients underwent three sessions of fractional CO₂ vaginal laser therapy at 28–30-day intervals. Statistical analysis was performed using SigmaPlot 11.0, with p < 0.05 considered significant.
Results. CO₂ laser therapy resulted in significant improvement in VAS-assessed symptoms, including vaginal atrophy, dryness, itching, dyspareunia, and SUI severity. Total UDI-6 scores decreased significantly after treatment. Ultrasound assessment showed a significant reduction in urethral descent during Valsalva. Baseline urethral mobility during voluntary contraction emerged as a potential predictor of therapeutic response. Improvement in sexual function was observed but did not reach statistical significance.
Conclusions. Fractional CO₂ laser therapy appears to be an effective minimally invasive option for women with mild-to-moderate SUI and vulvovaginal atrophy. Pretreatment urethral functional parameters may help identify patients most likely to benefit. Further large-scale randomized studies are needed to confirm these findings.
Downloads
References
Wu JM. Stress incontinence in women. N Engl J Med. 2021;384(25):2428–2436. https://doi.org/10.1056/NEJMcp1914037. DOI: https://doi.org/10.1056/NEJMcp1914037
Zalewski M, Kołodyńska G, Nowak K, Piątek A, Fink-Lwow F, Mucha A, Andrzejewski W. Quality of life and anxiety 12 and 36 months after surgical SUI treatment in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2024;295:153–159. https://doi.org/10.1016/j.ejogrb.2024.02.014. DOI: https://doi.org/10.1016/j.ejogrb.2024.02.014
Rzymski P, Burzyński B, Knapik M, Kociszewski J, Wilczak M. How to balance the treatment of stress urinary incontinence among female athletes? Arch Med Sci. 2021;17(2):314–322. https://doi.org/10.5114/aoms.2020.100139. DOI: https://doi.org/10.5114/aoms.2020.100139
Burzyński B, Gibała P, Sołtysiak-Gibała Z, Jurys T, Przymuszała P, Rzymski P, Stojko R. How urinary incontinence affects sexual activity in Polish women: results from a cross-sectional study. Int J Environ Res Public Health. 2022;19(21):13818. https://doi.org/10.3390/ijerph192113818. DOI: https://doi.org/10.3390/ijerph192113818
Burzyński B, Kwiatkowska K, Sołtysiak-Gibała Z, Bryniarski P, Przymuszała P, Wlaźlak E, Rzymski P. Impact of stress urinary incontinence on female sexual activity. Eur Rev Med Pharmacol Sci. 2021;25(2):643–653. https://doi.org/10.26355/eurrev_202101_24622.
Burzyński B, Jurys T, Knapik M, Burzyński K, Rzymski P, Rajwa P, Bryniarski P. Abdominal complex muscle in women with stress urinary incontinence: a prospective case-control study. Arch Med Sci. 2023;19(4):1016–1021. https://doi.org/10.5114/aoms/135708. DOI: https://doi.org/10.5114/aoms/135708
Mortensen OE, Christensen SE, Løkkegaard E. The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: a state-of-the-art review. Acta Obstet Gynecol Scand. 2022;101(6):657–692. https://doi.org/10.1111/aogs.14353. DOI: https://doi.org/10.1111/aogs.14353
Lee P, Perruzza D, Edell H, Jarvi S, Kim K, Sultana R, et al. Double-blind randomized controlled trial of Er:YAG vaginal laser to treat female stress urinary incontinence. Am J Obstet Gynecol. 2025;232(6):541.e1–541.e12. https://doi.org/10.1016/j.ajog.2024.11.021. DOI: https://doi.org/10.1016/j.ajog.2024.11.021
Dams SD, de Liefde-van Beest M, Nuijs AM, Oomens CWJ, Baaijens FPT. Heat shocks enhance procollagen type I and III expression in fibroblasts in ex vivo human skin. Skin Res Technol. 2011;17(2):167–180. https://doi.org/10.1111/j.1600-0846.2010.00473.x. DOI: https://doi.org/10.1111/j.1600-0846.2010.00473.x
Kwon TR, Kim JH, Seok J, Kim JM, Bak DH, Choi MJ, et al. Fractional CO₂ laser treatment for vaginal laxity: a preclinical study. Lasers Surg Med. 2018;50(9):940–947. https://doi.org/10.1002/lsm.22940. DOI: https://doi.org/10.1002/lsm.22940
Ruffolo AF, Braga A, Torella M, Frigerio M, Cimmino C, De Rosa A, et al. Vaginal laser therapy for female stress urinary incontinence: new solutions for a well-known issue—a concise review. Medicina (Kaunas). 2022;58(4):512. https://doi.org/10.3390/medicina58040512. DOI: https://doi.org/10.3390/medicina58040512
Gambacciani M, Cervigni M. FDA warns against use of energy-based devices: the VELA Safety Communication. Biomed J Sci Tech Res. 2018;12(2). https://doi.org/10.26717/BJSTR.2018.12.002224. DOI: https://doi.org/10.26717/BJSTR.2018.12.002224
Dumoulin C, Hay-Smith EJC, Mac Habée-Séguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2014;(5):CD005654. https://doi.org/10.1002/14651858.CD005654.pub3. DOI: https://doi.org/10.1002/14651858.CD005654.pub3
Tadir Y, Gaspar A, Lev-Sagie A, Alexiades M, Alinsod R, Bader A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med. 2017;49(2):137–159. https://doi.org/10.1002/lsm.22637. DOI: https://doi.org/10.1002/lsm.22637
Salvatore S, Pitsouni E, Grigoriadis T, Zacharakis D, Pantaleo G, Candiani M, Athanasiou S. CO₂ laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial. Climacteric. 2021;24(2):187–193. https://doi.org/10.1080/13697137.2020.1829584. DOI: https://doi.org/10.1080/13697137.2020.1829584
Salvatore S, França K, Lotti T, Parma M, Palmieri S, Candiani M, et al. Early regenerative modifications of human postmenopausal atrophic vaginal mucosa following fractional CO₂ laser treatment. Open Access Maced J Med Sci. 2018;6(1):6–14. https://doi.org/10.3889/oamjms.2018.058. DOI: https://doi.org/10.3889/oamjms.2018.058
European Association of Urology (EAU). Guidelines on Non-neurogenic Female Lower Urinary Tract Symptoms. Arnhem, The Netherlands: EAU; 2025. No DOI available.
National Institute for Health and Care Excellence (NICE). Urinary incontinence and pelvic organ prolapse in women: management. NICE Guideline NG123. London: NICE; updated 2021. No DOI available.
Behnia-Willison F, Nguyen TTT, Mohamadi B, Vancaillie TG, Lam A, Willison NN, et al. Fractional CO₂ laser for treatment of stress urinary incontinence. Eur J Obstet Gynecol Reprod Biol X. 2019;1:100004. https://doi.org/10.1016/j.eurox.2019.100004. DOI: https://doi.org/10.1016/j.eurox.2019.100004
Lauterbach R, Dabaja H, Matanes E, Gruenwald I, Lowenstein L. The efficacy and safety of CO₂ laser treatment for sexual function and vaginal laxity improvement in pre-menopausal women. Lasers Surg Med. 2021;53(2):199–203. https://doi.org/10.1002/lsm.23263. DOI: https://doi.org/10.1002/lsm.23263
Seki AS, Bianchi-Ferraro AMHM, Fonseca ESM, Sartori MGF, Girão MJBC, Jarmy-Di Bella ZIK. CO₂ laser and radiofrequency compared to a sham control group in treatment of stress urinary incontinence (LARF study arm 3): a randomized controlled trial. Int Urogynecol J. 2022;33(12):3535–3542. https://doi.org/10.1007/s00192-022-05091-y. DOI: https://doi.org/10.1007/s00192-022-05091-y
Alexander JW, Karjalainen P, Ow LL, Kulkarni M, Lee JK, Karjalainen T, et al. CO₂ surgical laser for treatment of stress urinary incontinence in women: a randomized controlled trial. Am J Obstet Gynecol. 2022;227(3):473.e1–473.e12. https://doi.org/10.1016/j.ajog.2022.05.054. DOI: https://doi.org/10.1016/j.ajog.2022.05.054
Sigurdardóttir HB, Kirschner B, Obel J, Aziz M, Blegvad Stenz C, Bennekou Schroll J. Vaginal CO₂ laser treatment for urinary stress incontinence: a randomized controlled trial. Maturitas. 2025;199:108658. https://doi.org/10.1016/j.maturitas.2025.108658. DOI: https://doi.org/10.1016/j.maturitas.2025.108658
Nalewczynska AA, Barwijuk M, Kolczewski P, Dmoch-Gajzlerska E. Pixel-CO₂ laser for the treatment of stress urinary incontinence. Lasers Med Sci. 2022;37(2):1061–1067. https://doi.org/10.1007/s10103-021-03353-7. DOI: https://doi.org/10.1007/s10103-021-03353-7
Downloads
Published
Issue
Section
License
Copyright (c) 2026 The copyright to the submitted manuscript is held by the Author, who grants the Journal of Medical Science (JMS) a nonexclusive licence to use, reproduce, and distribute the work, including for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
